v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2011
Operating activities      
Net income $ 41,104 $ 48,296 $ 8,512
Less: Discontinued operations, net of tax     (12,167)
Income from continuing operations 41,104 48,296 20,679
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:      
Depreciation and amortization 17,374 14,166 5,694
Gain on early extinguishment of debt (1,000)    
Stock compensation expense 13,379 12,117 9,136
Inventory allowance (1,122) 884 (22)
Doubtful accounts (357) 117 221
Deferred tax (benefit) expense (6,852) (1,719) 66
Incremental tax benefit from exercise of common stock options (8,588) (16,953) (6,597)
Changes in operating assets and liabilities:      
Accounts receivable (7,466) (1,596) (1,809)
Inventory (7,470) (132) (392)
Prepaid expenses and other assets 14,217 17,890 7,815
Accounts payable 6,542 (7,570) 1,552
Accrued expenses and other (2,341) (8,534) (691)
Profit-sharing distributions payable 274 (3,226) 1,671
Customer payables (4,768) 2,510 2,945
Acquisition earn out payable (5,985) (3,826) 358
Other liabilities (198) 205 (1)
Net cash provided by operating activities from continuing operations 46,743 52,629 40,625
Net cash used by operating activities from discontinued operations   (483) (739)
Net cash provided by operating activities 46,743 52,146 39,886
Investing activities      
Purchases of short-term investments     (10,292)
Proceeds from the sale of short-term investments     43,812
Cash paid for acquisitions and increase in goodwill and intangibles (14,730) (71,796) (9,092)
Purchases of property and equipment (5,463) (6,793) (4,822)
Net cash (used in) provided by investing activities (20,193) (78,589) 19,606
Financing activities      
Principal repayments of debt (39,000)    
Repurchases of common stock   (29,999) (3,541)
Proceeds from exercise of common stock options (net of tax) 2,532 15,491 23,639
Incremental tax benefit from exercise of common stock options 8,588 16,953 6,597
Payment of acquisition contingent liabilities (8,185)    
Net cash (used in) provided by financing activities (36,065) 2,445 26,695
Effect of exchange rate differences on cash and cash equivalents (158) (309) (476)
Net increase (decrease) in cash and cash equivalents (9,673) (24,307) 85,711
Cash and cash equivalents at beginning of year 104,782 129,089 43,378
Cash and cash equivalents at end of year 95,109 104,782 129,089
Less: Cash and cash equivalents of discontinued operations at end of year     105
Cash and cash equivalents of continuing operations at end of year 95,109 104,782 128,984
Supplemental disclosure of cash flow information      
Cash paid for income taxes 16,760 14,482 6,245
Cash paid for interest 2,034 117 62
Note payable issued in connection with acquisition   40,000  
Contingent purchase price accrued $ 18,390 $ 7,438 $ 6,989